Medical-device companies are doing well because elective-procedure volumes are finally back to their pre-pandemic levels—and are now even higher than those levels in many cases. To the extent that SWAV's procedures can be considered elective, SWAV ought to be a beneficiary of this trend.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”